Lactase deficiency: A potential novel aetiological factor in chronic pruritus of unknown origin

Acta Dermato-Venereologica

Volumn 91, Issue 6, 2011, Pages 698-703

  Grundmann, Sonja A ^a   Stratmann, Ewelina ^a   Brehler, Randolf ^a   Luger, Thomas A ^a   Ständer, Sonja ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

Diet; Itch; Lactose intolerance; Lactose malabsorption

Indexed keywords

LACTASE; LACTOSE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHRONIC DISEASE; DEMOGRAPHY; DIET THERAPY; DISEASE DURATION; DISEASE SEVERITY; FEMALE; HUMAN; LACTASE DEFICIENCY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PRURITUS; RISK FACTOR; SCREENING; TREATMENT INDICATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHRONIC DISEASE; FEMALE; HUMANS; LACTASE; LACTOSE; LACTOSE INTOLERANCE; MALE; MIDDLE AGED; PILOT PROJECTS; PRURITUS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; YOUNG ADULT;

EID: 80054930141     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/00015555-1150     Document Type: Article

References (37)

1. Yosipovitch G, Greaves MW, Schmelz M. Itch. Lancet 2003; 361: 690-694.
2. Sheehan-Dare RA, Henderson MJ, Cotterill JA. Anxiety and depression in patients with chronic urticaria and generalized pruritus. Br J Dermatol 1990; 123: 769-774.
3. Ikoma A, Steinhoff M, Stander S, Yosipovitch G, Schmelz M. The neurobiology of itch. Nat Rev Neurosci 2006; 7: 535-547.
4. Ständer S, Streit M, Darsow U, Niemeier V, Vogelgsang M, Ständer H, et al. Diagnostisches und therapeutisches Vorgehen beichronischem Pruritus. J Dtsch Dermatol Ges 2006; 4: 350-370.
5. Narita I, Iguchi S, Omori K, Gejyo F. Uremic pruritus in chronic hemodialysis patients. J Nephrol 2008; 21: 161-165.
6. Bergasa NV. Update on the treatment of the pruritus of cholestasis. Clin Liver Dis 2008; 12: 219-234.
7. Jones EA, Bergasa NV. The pruritus of cholestasis and the opioid system. JAMA 1992; 268: 3359-3362.
8. Schneider G, Driesch G, Heuft G, Evers S, Luger TA, Ständer S. Psychosomatic cofactors and psychiatric comorbidity in patients with chronic itch. Clin Exp Dermatol 2006; 31: 762-767.
9. Sommer F, Hensen P, Bockenholt B, Metze D, Luger TA, Ständer S. Underlying diseases and co-factors in patients with severe chronic pruritus: a 3-year retrospective study. Acta Derm Venereol 2007; 87: 510-516.
10. Weisshaar E, Dalgard F. Epidemiology of itch: adding to the burden of skin morbidity. Acta Derm Venereol 2009; 89: 339-350.
11. Treudler R, Tebbe B, Steinhoff M, Orfanos CE. Familial aquagenic urticaria associated with familial lactose intolerance. J Am Acad Dermatol 2002; 47: 611-613.
12. Matthews SB, Waud JP, Roberts AG, Campbell AK. Systemic lactose intolerance: a new perspective on an old problem. Postgrad Med J 2005; 81: 167-173.
13. Nenoff P, Domula E, Willing U, Herrmann J. Giardia lamblia - Ursache von Urtikaria und Pruritus oder zufällige Assoziation? Hautarzt 2006; 57: 518-522.
14. Voelker R. NIH panel tackles lactose intolerance. JAMA 2010; 303: 1240-1242.
15. Brannon PM, Carpenter TO, Fernandez JR, Gilsanz V, Gould JB, Hall KE, et al. NIH Consensus Development Conference Statement: Lactose Intolerance and Health. NIH Consens State Sci Statements 2010; 27.
16. Vesa TH, Marteau P, Korpela R. Lactose intolerance. J Am Coll Nutr 2000; 19: 165S-175S.
17. Campbell AK, Waud JP, Matthews SB. The molecular basis of lactose intolerance. Sci Prog 2009; 92: 241-287.
18. Stander S, Weisshaar E, Mettang T, Szepietowski JC, Carstens E, Ikoma A, et al. Clinical classification of itch: a position paper of the International Forum for the Study of Itch. Acta Derm Venereol 2007; 87: 291-294.
19. Lotts T, Klein D, Chatzigeorgakidis E, Iking A, Phan NQ, Ständer S. Multidimensional database for pruritus patients - statistical evaluation of clinical characteristics Acta Derm Venereol 2009; 89: 691.
20. Beyerlein L, Pohl D, Delco F, Stutz B, Fried M, Tutuian R. Correlation between symptoms developed after the oral ingestion of 50 g lactose and results of hydrogen breath testing for lactose intolerance. Aliment Pharmacol Ther 2008; 27: 659-665.
21. Bodlaj G, Stocher M, Hufnagl P, Hubmann R, Biesenbach G, Stekel H, et al. Genotyping of the lactase-phlorizin hydrolase -13910 polymorphism by LightCycler PCR and implications for the diagnosis of lactose intolerance. Clin Chem 2006; 52: 148-151.
22. Enattah NS, Sahi T, Savilahti E, Terwilliger JD, Peltonen L, Jarvela I. Identification of a variant associated with adulttype hypolactasia. Nat Genet 2002; 30: 233-237.
23. Enattah NS, Trudeau A, Pimenoff V, Maiuri L, Auricchio S, Greco L, et al. Evidence of still-ongoing convergence evolution of the lactase persistence T-13910 alleles in humans. Am J Hum Genet 2007; 81: 615-625.
24. Kuokkanen M, Kokkonen J, Enattah NS, Ylisaukko-Oja T, Komu H, Varilo T, et al. Mutations in the translated region of the lactase gene (LCT) underlie congenital lactase deficiency. Am J Hum Genet 2006; 78: 339-344.
25. Steinhoff M, Bienenstock J, Schmelz M, Maurer M, Wei E, Biro T. Neurophysiological, neuroimmunological, and neuroendocrine basis of pruritus. J Invest Dermatol 2006;126: 1705-1718.
26. Pogatzki-Zahn E, Marziniak M, Schneider G, Luger TA, Ständer S. Chronic pruritus: targets, mechanisms and future therapies. Drug News Perspect 2008; 21: 541-551.
27. Grundmann SA, Ständer S. Aminosäuresequenzhomologie zum NF-kappa B repressing factor (NKRF): Schlüsselfaktor bei Laktoseintoleranz-vermitteltem Pruritus?. J Dtsch Dermatol Ges 2009; 7: 1015.
28. Bartels M, Schweda AT, Dreikhausen U, Frank R, Resch K, Beil W, et al. Peptide-mediated disruption of NFkappaB/NRF interaction inhibits IL-8 gene activation by IL-1 or Helicobacter pylori. J Immunol 2007; 179: 7605-7613.
29. Han SJ, Ryu SN, Trinh HT, Joh EH, Jang SY, Han MJ, et al. Metabolism of cyanidin-3-O-beta-D-glucoside isolated from black colored rice and its antiscratching behavioral effect in mice. J Food Sci 2009; 74: 253-258.
30. Sur R, Nigam A, Grote D, Liebel F, Southall MD. Avenanthramides, polyphenols from oats, exhibit anti-inflammatory and anti-itch activity. Arch Dermatol Res 2008; 300: 569-574.
31. Sancho R, Calzado MA, Di Marzo V, Appendino G, Munoz E. Anandamide inhibits nuclear factor-kappa B activation through a cannabinoid receptor-independent pathway. Mol Pharmacol 2003; 63: 429-438.
32. Diehn F, Tefferi A. Pruritus in polycythaemia vera: prevalence, laboratory correlates and management. Br J Haematol 2001; 115: 619-621.
33. Spivak JL. Narrative review: thrombocytosis, polycythemia vera, and JAK2 mutations: The phenotypic mimicry of chronic myeloproliferation. Ann Intern Med 2010;152: 300-306.
34. Tefferi A, Gilliland DG. The JAK2V617F tyrosine kinase mutation in myeloproliferative disorders: status report and immediate implications for disease classification and diagnosis. Mayo Clin Proc 2005; 80: 947-958.
35. Vannucchi AM, Antonioli E, Guglielmelli P, Rambaldi A, Barosi G, Marchioli R, et al. Clinical profile of homozygous JAK2 617V>F mutation in patients with polycythemia vera or essential thrombocythemia. Blood 2007; 110: 840-846.
36. Ganster RW, Taylor BS, Shao L, Geller DA. Complex regulation of human inducible nitric oxide synthase gene transcription by Stat 1 and NF-kappa B. Proc Natl Acad Sci USA 2001; 98: 8638-8643.
37. Dreikhausen U, Hiebenthal-Millow K, Bartels M, Resch K, Nourbakhsh M. NF-kappa B-repressing factor inhibits elongation of human immunodeficiency virus type 1 transcription by DRB sensitivity-inducing factor. Mol Cell Biol 2005; 25: 7473-7483.